"The EPA issued a response, published this week in the Federal Register, which upholds Hirzy's finding that pharmaceutical-grade sodium fluoride contains about 100 times less arsenic than fluorosilicic acid does, and thus carries a 100-fold lower risk of cancer. Nonetheless, the EPA said the cost of switching to sodium fluoride is prohibitive."